In-Person Event Apr 14th
CRISPRMED26 Speakers
The 3rd edition of the CRISPR MEDiCiNE Conference will take place in Copenhagen, Denmark from April 13th - 16th 2026.
This premier annual event shines a spotlight on critical breakthroughs and challenges in CRISPR medicine - from cutting-edge tools and delivery systems to safety, regulation, functional genomics, pre-clinical pipelines, and advances in clinical trials.
Learn - Innovate - Access
Keynote Speakers
Confirmed Speakers Scientific Conference (list is updating)
Michel Sadelain, MD, PhD, Director of the Columbia Initiative in Cell Engineering and Therapy (CICET), Director of the Medical Center’s Cancer Cell Therapy Initiative in the Herbert Irving Comprehensive Cancer Center, USA (Note: this keynote lecture will now take place virtually on Wednesday 15th at 15:00 CET. More details to follow)
Paula Rio, PhD, Head of the Bone Marrow Failure Unit at CIEMAT/CIBERER/IIS-FJD at the Universidad Autónoma in Madrid, Spain.
---
Alessia Cavazza, Ass. Prof., Group Leader, Infection, Immunity & Inflammation Department at University College London's Great Ormond Street Institute of Child Health, England.
Anastasia Conti, Postdoc, Project Leader, San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), Milan, Italy.
André Cohnen, VP and Head of Gene Editing, Bayer Pharmaceuticals, Germany.
Andrew Sewell, Distinguished Research Prof. & Welcome Trust Senior Investigator, Cardiff University School of Medicine, UK.
Carla Fuster García, Postdoc, Institute for Transfusion Medicine and Gene Therapy, Universitätsklinikum Freiburg, Germany.
Cecilia Jiménez-Mallebrera, PhD and Research Director, Institut de Recerca Sant Joan de Déu. Hospital Sant Joan de Déu Barcelona and CIBERER, Spain.
Giorgio Galli, PhD, Group Leader, Oncology Drug Discovery Biology Unit, Novartis Institute for Biomedical Research, Basel, Switzerland.
Jakob Nilsson, Prof., PhD, Danish Cancer Institute, Copenhagen, Denmark.
Jan Gorodkin, Prof. and Group Leader, University of Copenhagen, Denmark.
Jonas Højfeldt, PhD, Sr. Director of RNA Therapeutics, Novo Nordisk, Denmark.
Julian Grünewald, Assistant Professor, Technical University of Munich, Germany.
Karim Benabdel Lah El Khlanji, Senior Scientist, GENyO Pfizer-University of Granada-Junta de Andalucia Center for Genomics and Oncological Research in Granada, Spain, GeneHumdi Action Chair.
Laura Torella, Postdoc, AstraZeneca, Sweden.
Laurent Poirot, SVP Immunology and Translational Science, Cellectis, France.
Marcello Maresca, Senior Director, Genome Engineering Team, AstraZeneca, Sweden.
Mathew Garnett, Dr., PhD, Senior Group Leader, Wellcome Sanger Institute & Co-founder of Mosaic Therapeutics, UK.
Nerea Zabaleta, Ass. Prof., Principal Investigator, Next Generation Gene Delivery Technologies Group, University of Navarra (CIMA), Spain.
Özcan Met, PhD, Ass. Prof., Head of Cell Therapy Unit at the National Center for Cancer Immune Therapy (CCIT-DK) at Herlev University Hospital and DTU HealthTech, Denmark.
Peter Haahr, PhD, Ass. Prof, Group leader, Center for Gene Expression, Department of Cellular and Molecular Medicine, University of Copenhagen, Denmark.
Phil Lorenz, PhD, Chief Technology Officer, Basecamp Research, UK
Rimvyde Cepaite, PhD Student, VU LSC-EMBL Partnership Institute for Genome Editing Technologies, Vilnius, Lithuania.
Roberta Esposito, Postdoc, Senior Scientist, Department for BioMedical Research (DBMR), University of Bern, Switzerland.
Sean Semple, Dr., Vice President of Preclinical Research, Acuitas Therapeutics, Canada.
Confirmed Scientific Speakers
Industry Speakers Scientific Conference
